In blood, melanoma patients harbored a decrease in frequencies of DCIR+ and Clec-9α+ cDC1s as well as an increase in expression level (MFI) of Clec-12α on cDC1s when compared to HDs (Figure 2D; Supplementary Figure 5D). Here, CLEC4A is linked to melanoma.